Redona Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
Redona Therapeutics General Information
Description
Developer of RNA drugs designed to treat cancer and other human diseases. The company's drugs are developed by researching short non-coding RNAs that inhibit target gene expression by suppressing mRNA translation and promoting mRNA decay, and developing small molecules that can modulate levels of miRNAs by targeting proteins that interact with these, enabling health advisors to target miRNAs that are directly involved in cancer initiation, progression, and metastasis.
Contact Information
Website
www.redonatx.comCorporate Office
- 490 Arsenal Way
- Suite 100B
- Watertown, MA 02472
- United States
Corporate Office
- 490 Arsenal Way
- Suite 100B
- Watertown, MA 02472
- United States
Redona Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 5. Later Stage VC | 31-Jul-2023 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series A) | 16-Jun-2022 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A) | 05-Apr-2016 | Completed | Startup | |||
| 2. University Spin-Out | 01-Jan-2016 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Redona Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Redona Therapeutics Comparisons
Industry
Financing
Details
Redona Therapeutics Competitors (100)
One of Redona Therapeutics’s 100 competitors is Silexion Therapeutics, a Formerly VC-backed company based in Ramat-Gan, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Silexion Therapeutics | Formerly VC-backed | Ramat-Gan, Israel | ||||
| WaVe Life Sciences | Formerly VC-backed | Cambridge, MA | ||||
| Sirnaomics | Formerly VC-backed | Gaithersburg, MD | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Atalanta Therapeutics | Venture Capital-Backed | Boston, MA |
Redona Therapeutics Patents
Redona Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023196629-A1 | Benzo[h]quinazoline-4-amine derivatives for the treatment of cancer | Inactive | 07-Apr-2022 | ||
| AU-2022374702-A1 | Benzo[h]quinazoline-4-amine derivatives for the treatment of cancer | Pending | 25-Oct-2021 | ||
| CA-3236083-A1 | Benzo[h]quinazoline-4-amine derivatives for the treatment of cancer | Pending | 25-Oct-2021 | ||
| EP-4423070-A1 | Benzo[h]quinazoline-4-amine derivatives for the treatment of cancer | Pending | 25-Oct-2021 | ||
| US-20260159486-A1 | Benzo[h]quinazoline-4-amine derivatives for the treatment of cancer | Pending | 25-Oct-2021 | C07D239/94 |
Redona Therapeutics Signals
Redona Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Longwood Fund Management | Venture Capital | Minority | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| Osage University Partners | Venture Capital | Minority | ||
| Sofinnova Partners | Venture Capital | Minority |
Redona Therapeutics FAQs
-
When was Redona Therapeutics founded?
Redona Therapeutics was founded in 2016.
-
Where is Redona Therapeutics headquartered?
Redona Therapeutics is headquartered in Watertown, MA.
-
What is the size of Redona Therapeutics?
Redona Therapeutics has 22 total employees.
-
What industry is Redona Therapeutics in?
Redona Therapeutics’s primary industry is Drug Discovery.
-
Is Redona Therapeutics a private or public company?
Redona Therapeutics is a Private company.
-
What is Redona Therapeutics’s current revenue?
The current revenue for Redona Therapeutics is .
-
How much funding has Redona Therapeutics raised over time?
Redona Therapeutics has raised $89.7M.
-
Who are Redona Therapeutics’s investors?
Johnson & Johnson JJDC, Longwood Fund Management, Novartis Venture Fund, Osage University Partners, and Sofinnova Partners are 5 of 9 investors who have invested in Redona Therapeutics.
-
Who are Redona Therapeutics’s competitors?
Silexion Therapeutics, WaVe Life Sciences, Sirnaomics, Intellia Therapeutics, and Atalanta Therapeutics are some of the 100 competitors of Redona Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process